Multicenter prospective validation of the Baveno IV and Baveno II/III criteria in cirrhosis patients with variceal bleeding

Hepatology

Volumn 61, Issue 3, 2015, Pages 1024-1032

  Thabut, Dominique ^a   Rudler, Marika ^a   Dib, Nina ^b   Carbonell, Nicolas ^c   Mathurin, Philippe ^d   Saliba, Faouzi ^e   Mallet, Alain ^a   Massard, Julien ^a   Bernard Chabert, Brigitte ^f   Oberti, Frederic ^b   Cales, Paul ^b   Golmard, Jean Louis ^a   Bureau, Christophe ^g  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

^c HÔPITAL SAINT ANTOINE   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

^e HÔPITAL PAUL BROUSSE   (France)

^f REIMS UNIVERSITY HOSPITAL   (France)

^g TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; VASOACTIVE AGENT;

ADJUSTED BLOOD REQUIREMENT INDEX; ADULT; ANTIBIOTIC THERAPY; ARTICLE; ASSESSMENT OF HUMANS; BAVENO II III CRITERIA; BAVENO IV CRITERIA; BLOOD; BLOOD TRANSFUSION; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CONTROL; ESOPHAGUS VARICES BLEEDING; FALSE POSITIVE RESULT; GOLD STANDARD; HEALTH CARE POLICY; HEMATOCRIT; HUMAN; KAPPA STATISTICS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RATING SCALE; SENSITIVITY AND SPECIFICITY; STOMACH VARICES BLEEDING; SURVIVAL RATE; UPPER GASTROINTESTINAL BLEEDING; VALIDATION STUDY; CLINICAL TRIAL; COMPLICATION; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; MORTALITY; TREATMENT FAILURE;

BLOOD TRANSFUSION; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; HUMANS; LIVER CIRRHOSIS; PROSPECTIVE STUDIES; TREATMENT FAILURE;

EID: 84923285979     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.27407     Document Type: Article

References (19)

1. Bosch J, Thabut D, Albillos A, Carbonell N, Spicak J, Massard J, et al. Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: a randomized, controlled trial. Hepatology 2008;47:1604-1614.
2. Villanueva C, Colomo A, Bosch A. Transfusion for acute upper gastrointestinal bleeding. N Engl J Med 2013;368:1362-1363.
3. Garcia-Pagan JC, Caca K, Bureau C, Laleman W, Appenrodt B, Luca A, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 2010;362:2370-2379.
4. Garcia-Pagan JC, Di Pascoli M, Caca K, Laleman W, Bureau C, Appenrodt B, et al. Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study. J Hepatol 2013;58:45-50.
5. Thabut D, Rudler M, Lebrec D. Early TIPS with covered stents in high-risk patients with cirrhosis presenting with variceal bleeding: are we ready to dive into the deep end of the pool? J Hepatol 2011;55:1148-1149.
6. de Franchis R. Developing consensus in portal hypertension. J Hepatol 1996;25:390-394.
7. de Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000;33:846-852.
8. Cales P, Masliah C, Bernard B, Garnier PP, Silvain C, Szostak-Talbodec N, et al. Early administration of vapreotide for variceal bleeding in patients with cirrhosis. N Engl J Med 2001;344:23-28.
9. Burroughs AK. Assessment of value of consensus definitions in acute variceal bleeding. Lancet 2001;357:1147-1148.
10. Cales P, Lacave N, Silvain C, Vinel JP, Besseghir K, Lebrec D. Prospective study on the application of the Baveno II Consensus Conference criteria in patients with cirrhosis and gastrointestinal bleeding. J Hepatol 2000;33:738-741.
11. de Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005;43:167-176.
12. de Franchis R. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010;53:762-768.
13. Thabut D, D'Amico G, Tan P, De Franchis R, Fabricius S, Lebrec D, et al. Diagnostic performance of Baveno IV criteria in cirrhotic patients with upper gastrointestinal bleeding: analysis of the F7 liver-1288 study population. J Hepatol 2010;53:1029-1034.
14. Fleiss J. The measurement of interrater agreement. New York: John Wiley & Sons; 1981.
15. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
16. Akhtar N, Zuberi BF, Hasan SR, Kumar R, Afsar S. Determination of correlation of Adjusted Blood Requirement Index with outcome in patients presenting with acute variceal bleeding. World J Gastroenterol 2009;15:2372-2375.
17. Duvnjak M, Barsic N, Tomasic V, Jukic LV, Lerotic I, Pavic T. Adjusted blood requirement index as indicator of failure to control acute variceal bleeding. Croat Med J 2006;47:398-403.
18. Ngo Y, Munteanu M, Messous D, Charlotte F, Imbert-Bismut F, Thabut D, et al. A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C. Clin Chem 2006;52:1887-1896.
19. Poynard T, de Ledinghen V, Zarski JP, Stanciu C, Munteanu M, Vergniol J, et al. Relative performances of FibroTest, Fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis C: a step toward the truth in the absence of a gold standard. J Hepatol 2012;56:541-548.